Long term term follow-up of tyrosine kinase inhibitors treatments in inoperable or relapsing diffuse type tenosynovial giant cell tumors (dTGCT)

RATIONALE: CSF1R tyrosine kinase inhibitors (TKI) and antibodies yield response rates and tumor control in patients with diffuse type tenosynovial giant cell tumors (dTGCT). The long term management of patients with dTGCT treated with TKI is however not known. PATIENTS AND METHODS: We conducted a re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Brahmi, Mehdi, Cassier, Philippe, Dufresne, Armelle, Chabaud, Sylvie, Karanian, Marie, Meurgey, Alexandra, Bouhamama, Amine, Gouin, Francois, Vaz, Gualter, Garret, Jerome, Sunyach, Marie-Pierre, Dupré, Aurélien, Marec-Berard, Perrine, Corradini, Nadège, Perol, David, Ray-Coquard, Isabelle, Blay, Jean-Yves
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7239463/
https://ncbi.nlm.nih.gov/pubmed/32433669
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0233046
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados